Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Kenji Hashimoto
Biochemical Pharmacology (2020) Vol. 177, pp. 113935-113935
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Brain–gut–microbiota axis in depression: A historical overview and future directions
Lijia Chang, Wei Yan, Kenji Hashimoto
Brain Research Bulletin (2022) Vol. 182, pp. 44-56
Open Access | Times Cited: 244
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 180
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
Wei Yao, Qianqian Cao, Shilin Luo, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1618-1629
Open Access | Times Cited: 158
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 2, pp. 249-258
Open Access | Times Cited: 115
Brain-spleen axis in health and diseases: A review and future perspective
Wei Yan, Tong Wang, Lei Liao, et al.
Brain Research Bulletin (2022) Vol. 182, pp. 130-140
Open Access | Times Cited: 88
S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial
Yaqian Han, Pule Li, Mengrong Miao, et al.
BMC Anesthesiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy
Di Qiu, Xingming Wang, Jin-Jin Yang, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2244514-e2244514
Open Access | Times Cited: 72
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 51
Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options
Akash Kumar, Jhilam Pramanik, Nandani Goyal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 565-565
Open Access | Times Cited: 48
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents
Wei Yao, Song Lin, Jin Su, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 79
Ketamine for depression
Luke A. Jelen, James Stone
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 207-228
Closed Access | Times Cited: 70
Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
Ketamine and its metabolites: Potential as novel treatments for depression
Kai Zhang, Yitan Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 222, pp. 109305-109305
Closed Access | Times Cited: 60
(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis
Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105635-105635
Open Access | Times Cited: 52
Esketamine alleviates postoperative depression-like behavior through anti-inflammatory actions in mouse prefrontal cortex
Tianyuan Wang, Huandi Weng, Hongji Zhou, et al.
Journal of Affective Disorders (2022) Vol. 307, pp. 97-107
Closed Access | Times Cited: 50
Novel Pharmacological Approaches to the Treatment of Depression
Elias Elias, Ariel Y. Zhang, Melissa T. Manners
Life (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 48
Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota
Xiayun Wan, Akifumi Eguchi, Yūkō Fujita, et al.
Neuropharmacology (2022) Vol. 213, pp. 109139-109139
Open Access | Times Cited: 43
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Xingming Wang, Jianjun Yang, Kenji Hashimoto
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104762-104762
Open Access | Times Cited: 41
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A. Zarate, Gustavo Vázquez
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 853-866
Open Access | Times Cited: 40
Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial
Qingren Liu, Qian-Kun Zong, Lili Ding, et al.
Journal of Affective Disorders (2023) Vol. 339, pp. 815-822
Open Access | Times Cited: 40
A role of gut–microbiota–brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice
Yong Yang, Akifumi Eguchi, Xiayun Wan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110652-110652
Open Access | Times Cited: 39
Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine
Li Ma, Jiancheng Zhang, Yūkō Fujita, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 32
Neuroinflammation through the vagus nerve-dependent gut–microbiota–brain axis in treatment-resistant depression
Kenji Hashimoto
Progress in brain research (2023), pp. 61-77
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top